compounded semaglutide safety concerns Navigating Semaglutide: What Health Care Providers Need to Know FDA Warns Against Using Compounded

If you are taking any GLP-1 medication, you should proactively address constipation rather than waiting for it to become a problem

96 , 97 Cardiovascular safety was first established in the PIONEER 6 trial, 98 with the more recent SOUL trial demonstrating a significant reduction in MACE compared to placebo among individuals with type 2 diabetes and high cardiovascular or renal risk

Mounjaro (tirzepatide) : The SURMOUNT trials demonstrated even greater efficacy, with average weight loss of 22.5% at the highest dose after 72 weeks

Do not ignore these early warnings

Remove pizza from air fryer

Really a life changing decision